KMDA Q1 2021 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$25M-25.2% YoY

Gross Profit

$9M35.9% margin

Operating Income

$2M9.5% margin

Net Income

$3M10.8% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

-21.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$215,000

Balance Sheet

Total Assets

$211M

Total Liabilities

$29M

Stockholders' Equity

$181M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$33M	-25.2%
Gross Profit	$9M	$11M	-22.0%
Operating Income	$2M	$5M	-51.3%
Net Income	$3M	$5M	-48.5%